Removal of prostate tumor metastases with a gamma probe in University Hospital Carl Gustav Carus Dresden
University Hospital Carl Gustav Carus Dresden
Dresden, Germany
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the hospital<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Evaluating the available medical reports<\/li>\n\t<li>General clinical examination<\/li>\n\t<li>Urological examination<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>Complete blood count<\/li>\n\t\t<li>Biochemical analysis of blood<\/li>\n\t\t<li>Inflammation indicators (CRP, ESR)<\/li>\n\t\t<li>Indicators of blood coagulation<\/li>\n\t\t<li>Tumor markers, PSA<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Ultrasound scan of the urogenital system<\/li>\n\t<li>CT scan\/MRI of the abdomen and pelvis<\/li>\n\t<li>Preoperative care<\/li>\n\t<li>Removal of prostate tumor metastases with a gamma probe<\/li>\n\t<li>Consultations of related specialists<\/li>\n\t<li>Symptomatic treatment<\/li>\n\t<li>Cost of essential medicines<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Control examinations<\/li>\n\t<li>Stay in the hospital with full board<\/li>\n\t<li>Accommodation in 2-bedded ward<\/li>\n\t<li>Recommendations regarding further treatment<\/li>\n<\/ul>\n<div class=\"program_indications_for_surgery\"><h4>Indications<\/h4><ul>\n\t<li>Confirmed prostate cancer with suspected metastasizing<\/li>\n<\/ul>\n<\/div><div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the physician will conduct a clinical examination and go through the results of the available examinations. After that, you will undergo the necessary additional examination, such as the assessment of liver and kidney function, ultrasound scan of the abdominal and pelvic organs. Based on the results, the physician will determine the number and localization of metastases, and plan the upcoming intervention.<\/p>\n\n<p style=\"text-align:justify\"><strong>On the eve of the intervention<\/strong>, you will receive an injection of radioactively labeled PSMA. PSMA is the substance that binds to the smallest prostate cancer metastases in the lymph nodes and other tissues. The radioactive label will allow the surgeon to find all the metastases during the operation.<\/p>\n\n<p style=\"text-align:justify\"><strong>Removal of prostate tumor metastases with a gamma probe<\/strong> starts with general anesthesia. After anesthesia, the surgeon makes small incisions through which he inserts endoscopic instruments, a gamma probe and a video camera into the pelvic cavity and abdominal cavity. The gamma probe detects the lymph nodes affected by metastases by a radioactive label, and the surgeon removes them endoscopically. The video camera continuously transmits a three-dimensional image of the operating field in 12-fold magnification to the monitor.<\/p>\n\n<p style=\"text-align:justify\">As the surgeon sees the operating field in multiple magnification, he preserves the nerve endings and large blood vessels. This significantly reduces the surgical risks. The gamma probe, in turn, allows detecting and removing all metastases, which minimizes the risk of prostate cancer recurrence.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the completion of the operation<\/strong>, you will be transferred back to the ward, under the supervision of the attending physician and nursing staff. Due to the minimal invasiveness of the operation and the short duration of general anesthesia, you will not need to stay in the intensive care unit for a long time.<\/p>\n\n<p style=\"text-align:justify\">Finally, the attending physician will evaluate the results of control examinations, schedule the date of discharge from the hospital and give you detailed recommendations for further follow-up and treatment.<\/p>\n<\/div><div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li style=\"text-align: justify;\">Medical records<\/li>\n\t<li style=\"text-align: justify;\">PSA blood test<\/li>\n\t<li style=\"text-align: justify;\">MRI\/CT scan (not older than 3 months)<\/li>\n\t<li style=\"text-align: justify;\">Bone scintigraphy (if available)<\/li>\n\t<li style=\"text-align: justify;\">Biopsy results (if available)<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the hospital<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Evaluating the available medical reports<\/li>\n\t<li>General clinical examination<\/li>\n\t<li>Urological examination<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>Complete blood count<\/li>\n\t\t<li>Biochemical analysis of blood<\/li>\n\t\t<li>Inflammation indicators (CRP, ESR)<\/li>\n\t\t<li>Indicators of blood coagulation<\/li>\n\t\t<li>Tumor markers, PSA<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Ultrasound scan of the urogenital system<\/li>\n\t<li>CT scan\/MRI of the abdomen and pelvis<\/li>\n\t<li>Preoperative care<\/li>\n\t<li>Removal of prostate tumor metastases with a gamma probe<\/li>\n\t<li>Consultations of related specialists<\/li>\n\t<li>Symptomatic treatment<\/li>\n\t<li>Cost of essential medicines<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Control examinations<\/li>\n\t<li>Stay in the hospital with full board<\/li>\n\t<li>Accommodation in 2-bedded ward<\/li>\n\t<li>Recommendations regarding further treatment<\/li>\n<\/ul>\n<div class=\"program_indications_for_surgery\"><h4>Indications<\/h4><ul>\n\t<li>Confirmed prostate cancer with suspected metastasizing<\/li>\n<\/ul>\n<\/div><div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the physician will conduct a clinical examination and go through the results of the available examinations. After that, you will undergo the necessary additional examination, such as the assessment of liver and kidney function, ultrasound scan of the abdominal and pelvic organs. Based on the results, the physician will determine the number and localization of metastases, and plan the upcoming intervention.<\/p>\n\n<p style=\"text-align:justify\"><strong>On the eve of the intervention<\/strong>, you will receive an injection of radioactively labeled PSMA. PSMA is the substance that binds to the smallest prostate cancer metastases in the lymph nodes and other tissues. The radioactive label will allow the surgeon to find all the metastases during the operation.<\/p>\n\n<p style=\"text-align:justify\"><strong>Removal of prostate tumor metastases with a gamma probe<\/strong> starts with general anesthesia. After anesthesia, the surgeon makes small incisions through which he inserts endoscopic instruments, a gamma probe and a video camera into the pelvic cavity and abdominal cavity. The gamma probe detects the lymph nodes affected by metastases by a radioactive label, and the surgeon removes them endoscopically. The video camera continuously transmits a three-dimensional image of the operating field in 12-fold magnification to the monitor.<\/p>\n\n<p style=\"text-align:justify\">As the surgeon sees the operating field in multiple magnification, he preserves the nerve endings and large blood vessels. This significantly reduces the surgical risks. The gamma probe, in turn, allows detecting and removing all metastases, which minimizes the risk of prostate cancer recurrence.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the completion of the operation<\/strong>, you will be transferred back to the ward, under the supervision of the attending physician and nursing staff. Due to the minimal invasiveness of the operation and the short duration of general anesthesia, you will not need to stay in the intensive care unit for a long time.<\/p>\n\n<p style=\"text-align:justify\">Finally, the attending physician will evaluate the results of control examinations, schedule the date of discharge from the hospital and give you detailed recommendations for further follow-up and treatment.<\/p>\n<\/div>","is_ambulant":"0","bh_fee":0,"only_for_children":"2","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"0","clinic_icon":"6009356eb0bfe.jpg","city":"Dresden","clinic_site":"https:\/\/www.uniklinikum-dresden.de\/de","department_recommend":"0","country":"Germany","country_id":"1","clinic_name":"University Hospital Carl Gustav Carus Dresden","cinic_name":"University Hospital Carl Gustav Carus Dresden","department_id":"1777","duration":"5","direction":"Urology","min_duration":0,"clinic_id":"1286","paketPrice":850,"paket":"<ul>\n <li>Interpreter up to 3 hours<\/li>\n <li>Translation of 2 pages<\/li>\n<\/ul>","title":"Removal of prostate tumor metastases with a gamma probe","price":{"val":"0.00","type":"val"},"price_surcharge":0,"price_surcharge_clear":0,"extra_service_clinic":[{"id":"need_to_use_head_doctor","title":"Treatment by leading experts","type":"val","val":0,"req":0},{"id":"1_person_room","title":" Single room (whole period)","parent":"duration","type":"count_val","val":"130.00"},{"id":"2_person_room","title":" double room (whole period)","parent":"duration","type":"count_val","val":"90.00"},{"id":"attendant_place","title":"Accommodation for the accompanying person ","parent":"duration","type":"count_val","val":"90.00"}],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"21","distance":"9","airport_title":"Dresden"},{"id":"20","distance":"130","airport_title":"Leipzig"},{"id":"8","distance":"172","airport_title":"Berlin"}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}
Program id #
694725
Prof. Dr. med. Jörg Kotzerke
Department of Nuclear Medicine
Specialized in: nuclear medicine The program includes:
- Initial presentation in the hospital
- Clinical history taking
- Evaluating the available medical reports
- General clinical examination
- Urological examination
- Laboratory tests:
- Complete blood count
- Biochemical analysis of blood
- Inflammation indicators (CRP, ESR)
- Indicators of blood coagulation
- Tumor markers, PSA
- Ultrasound scan of the urogenital system
- CT scan/MRI of the abdomen and pelvis
- Preoperative care
- Removal of prostate tumor metastases with a gamma probe
- Consultations of related specialists
- Symptomatic treatment
- Cost of essential medicines
- Nursing services
- Control examinations
- Stay in the hospital with full board
- Accommodation in 2-bedded ward
- Recommendations regarding further treatment
Indications
- Confirmed prostate cancer with suspected metastasizing
How program is carried out
During the first visit, the physician will conduct a clinical examination and go through the results of the available examinations. After that, you will undergo the necessary additional examination, such as the assessment of liver and kidney function, ultrasound scan of the abdominal and pelvic organs. Based on the results, the physician will determine the number and localization of metastases, and plan the upcoming intervention.
On the eve of the intervention, you will receive an injection of radioactively labeled PSMA. PSMA is the substance that binds to the smallest prostate cancer metastases in the lymph nodes and other tissues. The radioactive label will allow the surgeon to find all the metastases during the operation.
Removal of prostate tumor metastases with a gamma probe starts with general anesthesia. After anesthesia, the surgeon makes small incisions through which he inserts endoscopic instruments, a gamma probe and a video camera into the pelvic cavity and abdominal cavity. The gamma probe detects the lymph nodes affected by metastases by a radioactive label, and the surgeon removes them endoscopically. The video camera continuously transmits a three-dimensional image of the operating field in 12-fold magnification to the monitor.
As the surgeon sees the operating field in multiple magnification, he preserves the nerve endings and large blood vessels. This significantly reduces the surgical risks. The gamma probe, in turn, allows detecting and removing all metastases, which minimizes the risk of prostate cancer recurrence.
After the completion of the operation, you will be transferred back to the ward, under the supervision of the attending physician and nursing staff. Due to the minimal invasiveness of the operation and the short duration of general anesthesia, you will not need to stay in the intensive care unit for a long time.
Finally, the attending physician will evaluate the results of control examinations, schedule the date of discharge from the hospital and give you detailed recommendations for further follow-up and treatment.
Required documents
- Medical records
- PSA blood test
- MRI/CT scan (not older than 3 months)
- Bone scintigraphy (if available)
- Biopsy results (if available)
Service
Price from:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select
You may also book:
Hospital directly:
Saving:
BookingHealth Price from:
About the department
The Department of Nuclear Medicine at the University Hospital Carl Gustav Carus Dresden offers the full range of diagnostics and treatment with therapeutic radionuclides. The department has been carrying out successful clinical activities for over 60 years, and therefore it has vast experience and outstanding achievements. The department has state-of-the-art medical equipment, thereby providing each patient with optimal medical care that meets the highest international standards. A special focus is placed on the treatment of benign and malignant thyroid diseases. The department cooperates closely with the specialized centers for breast cancer, prostate cancer, lung cancer and skin cancer. The specialists in the field of nuclear medicine also actively cooperate with doctors from the Comprehensive Cancer Center Dresden. Most diagnostic examinations are carried out on an outpatient basis, and therapeutic interventions most often take place in an 18-bed inpatient medical facility – one of the largest of this kind in Germany.
The Head Physician of the department is Prof. Dr. med. Jörg Kotzerke, who is deservedly proud of his successful clinical practice in nuclear medicine. The doctor has been working with methods of radioisotope diagnostics and treatment for more than 30 years, tirelessly demonstrating excellent results. His clinical activity is closely intertwined with his research work, reflected in more than 350 scientific publications, including in the international medical literature. Since 2007, Prof. Jörg Kotzerke has been a Board Member of the German Society of Nuclear Medicine (DGN), and as a Member of the European Association of Nuclear Medicine (EANM), he shares his knowledge and achievements with colleagues from other European countries.
A special focus is on the treatment of benign and malignant thyroid diseases. In addition, over the past two decades, the department's range of treatment has been significantly expanded. As of today, the focus of the department's doctors is on interventional radionuclide therapy for neuroendocrine tumors. Radioimmunotherapy is used for malignant lymphoma treatment.
The department has all modern devices to perform accurate diagnostics, including a gamma camera, PET-CT and PET-MRI scanners. The most common diagnostic tests include scintigraphy of the thyroid and parathyroid glands, lungs, brain, heart, and kidneys.
Radiation therapy for such thyroid diseases as thyrotoxicosis (thyroid hyperfunction) accounts for a large number of the therapeutic procedures. In addition, radiation therapy is highly effective for thyroid cancer treatment. The essence of radiation therapy is to take radioactive iodine in the form of a capsule or a special liquid, after which it is actively absorbed by the thyroid gland. The amount of radioactive iodine required for therapy is determined using an outpatient radioiodine test. The therapy is carried out on an inpatient basis only. As a rule, the hospitalization period does not exceed 3-5 days. The therapeutic effect is achieved 6-8 weeks after the procedure, and therefore the patient must be monitored by an endocrinologist and oncologist, as well as undergo follow-up examinations.
A particularly demanded therapeutic procedure is Lutetium-177 PSMA therapy in patients with metastatic prostate cancer. The isotope Lutetium-177 is injected to the patient intravenously, in the form of an infusion. Due to its specific properties, the PSMA ligand marked with Lutetium-177 targetedly binds to cancer cells and destroys them. As a rule, three procedures performed at an interval of 8 weeks are required to achieve the result. In addition to its high efficiency, Lutetium-177 PSMA therapy is well tolerated.
The department's diagnostic and therapeutic range of services includes:
| Diagnostics |
|
| Therapy |
|
| Other diagnostic and therapeutic options |
Curriculum vitae
University Education and Medical Practice
- 1977 - 1983 Study of Medicine at the Hannover Medical School.
- 1984 - 1988 Assistant Physician, Department of Nuclear Medicine and Special Biophysics, Hannover Medical School.
- 1985 Doctor of Medicine, Hannover Medical School.
- 1988 Board certification in Nuclear Medicine.
- 1989 - 1995 Senior Physician, Department of Nuclear Medicine and Special Biophysics, Hannover Medical School.
- 1991 Habilitation and Venia Legendi in Nuclear Medicine, Hannover Medical School.
- 1995 - 2002 Assistant Professor in Cardiovascular Nuclear Medicine, Department of Nuclear Medicine, Ulm University.
- 2000 - 2002 Managing Senior Physician, Department of Nuclear Medicine, University Hospital Ulm.
- Since 2002 Professor for Nuclear Medicine, Carl Gustav Carus Faculty of Medicines of the Dresden University of Technology and Medical Director of the Positron Emission Tomography Center at the Research Center Dresden-Rossendorf.
- Since 2002 Head of the Department of Nuclear Medicine at the University Hospital Carl Gustav Carus Dresden.
Main Clinical Focuses
- Diagnostics of tumors using positron emission tomography.
- Radionuclide therapy.
Memberships in Scientific Societies
- German Society of Nuclear Medicine (DGN).
- German Radiological Society (DRG).
- European Association of Nuclear Medicine (EANM).
- Society of Nuclear Medicine (SNM).
- German Cancer Society (DKG).
Photo: (с) depositphotos
Sources:
About hospital
According to the reputable Focus magazine, the University Hospital Carl Gustav Carus Dresden ranks among the top five German hospitals!
The hospital is the benchmark for modern high-quality medicine. Positioning itself as a maximum care medical facility, the hospital represents all medical fields. There are 26 specialized departments, 6 institutes and 17 interdisciplinary centers, which cooperate closely with the clinical and scientific facilities of the Faculty of Medicine. The basis of successful practice is excellent equipment, which is regularly updated, as well as highly qualified, experienced medical personnel: world famous doctors and professors work here for the benefit of patients.
In addition to its main goal of caring for patients, the hospital is also active in training and professional development of medical personnel, as well as in the field of public health care. The priority focus of the work is research activity, which allows the doctors to introduce the innovative diagnostic and therapeutic techniques into clinical practice.
A special feature of the hospital is also the diagnostics and treatment of rare diseases. State-of-the-art equipment and well-coordinated work of doctors of various medical specialties make it possible to timely recognize pathologies rarely encountered in medical practice and select the most effective therapy. Specialization in rare diseases include neurology, endocrinology, hematology/oncology, and rare autoimmune diseases.
The hospital has 1,410 beds for patient hospitalization. About 55,900 inpatients and more than 233,975 outpatients undergo treatment here annually. A large medical team, consisting of about 1,000 highly qualified doctors, as well as over 2,000 nursing staff take care of the patients' health. Each patient is guaranteed an individual approach and the most effective treatment in accordance with current clinical protocols.
It should be noted that the university hospital enjoys an impeccable reputation not only in Germany, but also far beyond its borders, including Arab countries, post-Soviet states, Great Britain and the United States. Patients from different parts of the world come here for high-quality treatment for diseases of any severity. The highest credit of patient confidence is the main indicator of the fruitful work of doctors.
Photo: (с) depositphotos
Accommodation in hospital
Patients rooms
The patients of the University Hospital Carl Gustav Carus Dresden live in comfortable rooms made in bright colors and equipped with everything necessary. The standard patient room includes an automatically adjustable bed, a bedside table with a sliding table, a wardrobe, a telephone and a TV. There is also Wi-Fi (free) in the patient rooms.
If desired, patients may live in enhanced comfort patient rooms. These patient rooms have a more sophisticated design, upholstered furniture and a safe for storing valuables.
Meals and Menus
The patients of the hospital are offered a tasty, healthy and varied three meals a day. The menu is based on local cuisine and seasonal food. If you for some reason do not eat certain products, please inform the medical staff of the hospital in advance, and you will be offered an individual menu. The nutrition provided in the hospital is certified in accordance with the quality standards of the German Nutrition Society (DGE) for catering in German hospitals.
Further details
Standard rooms include:
Shower
Toilet
TV
Religion
The religious services are available upon request.
Accompanying person
Your accompanying person may stay with you in your patient room or at the hotel of your choice during the inpatient program.
Hotel
You may stay at the hotel of your choice during the outpatient program. Our managers will support you for selecting the best option.
The hospital offers a full range of laboratory diagnostic procedures (general, hormonal, tests for tumor markers, infections, antibodies, etc.), genetic tests, various modifications of ultrasound scans, CT scans, MRI and PET / CT, angiography, myelography, biopsy and other examinations. Treatment with medications, endoscopic and robotic operations, stereotaxic interventions is carried out here, modern types of radiation therapy are also used. The hospital offers patients all the necessary therapeutic techniques.
- Cochlear implantation
- Deep brain stimulation
- Treatment of benign prostatic hyperplasia with green laser
- Da Vinci prostatectomy
- Bone marrow transplantation
These are head and neck tumors, hearloss, amyotrophic lateral sclerosis, epilepsy, Parkinson disease, infertility, malignant tumors of the reproductive system, congenital anomalies of the genital organs and the urinary system, urinary incontinence, blood clotting disorders, leukemia and other pathologies.
- Otolaryngology (Center for Cochlear Implantation)
- Neurology and Epileptology
- Urology
- Oncology
- Gastroenterology and Hepatology
About 1,000 highly qualified doctors work at the hospital.
